| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/02/2006 | US20060024697 Compositions and methods for binding agglomeration proteins |
| 02/02/2006 | US20060024696 Nucleic acid and polypeptide sequences from Lawsonia intracellularis and methods of using |
| 02/02/2006 | US20060024695 Incubating nucleic acid with primers, polymerase; hybridization; cleavage and detection of 3' nucleotide by change in fluorescent polarization |
| 02/02/2006 | US20060024694 bioassays for identifying modulators of retroviral integration via the ataxia telangiectasia mutated(ATM) and Rad3 related kinase pathway; drug screening |
| 02/02/2006 | US20060024693 for the identification of "pregnancy competent" oocytes; identifying female subjects, preferably human females having impaired fertility function; evaluating the efficacy of a putative fertility treatment |
| 02/02/2006 | US20060024692 Method for diagnosing non-small cell lung cancers |
| 02/02/2006 | US20060024691 Novel pathways in the etiology of cancer |
| 02/02/2006 | US20060024690 Normalization of data using controls |
| 02/02/2006 | US20060024689 Process for the purification of recombinant proteins from complex media and purified proteins obtained thereby |
| 02/02/2006 | US20060024688 Alterations of fibulin genes in macular degeneration |
| 02/02/2006 | US20060024687 In vitro evolution of nucleic acids and encoded polypeptide |
| 02/02/2006 | US20060024686 Detection of human papillomaviruses |
| 02/02/2006 | US20060024685 Novel sequence variants of multi-drug resistance genes, MDR1 and MRP1, and recombinant cells expressing MRP1 and MDR1 for assessment of drug penetration and disposition |
| 02/02/2006 | US20060024684 Prognostic markers for prediction of treatment response and/or survival of breast cell proliferative disorder patients |
| 02/02/2006 | US20060024683 Transcription factor of MHC class II genes, substances capable of inhibiting this transcription factor and medical uses of these substances |
| 02/02/2006 | US20060024682 Methods of identifying individuals at risk of perioperative bleeding, renal dysfunction or stroke |
| 02/02/2006 | US20060024681 Methods for producing a paired tag from a nucleic acid sequence and methods of use thereof |
| 02/02/2006 | US20060024680 A bicistronic DNA construct containing IRES of enterovirus and an amount of amantadine that inhibits the IRES-dependent translation activity in a dose-dependent manner without interfering the CAP-dependent translation |
| 02/02/2006 | US20060024679 Method for predicting the expression efficiency in cell-free expression systems |
| 02/02/2006 | US20060024678 Use of single-stranded nucleic acid binding proteins in sequencing |
| 02/02/2006 | US20060024677 Novel therapeutic targets in cancer |
| 02/02/2006 | US20060024676 Method of detecting epigenetic biomarkers by quantitative methyISNP analysis |
| 02/02/2006 | US20060024675 Nucleic acid probes and broad-range primers from regions in topoisomerase genes, and methods in which they are used |
| 02/02/2006 | US20060024674 Method for conducting the parallel identification of different nucleic acids |
| 02/02/2006 | US20060024673 Slc2as as modifiers of the p53 pathway and methods of use |
| 02/02/2006 | US20060024672 Verification of food origin based on nucleic acid pattern recognition |
| 02/02/2006 | US20060024671 Biopolymer marker indicative of disease state having a molecular weight of 1525 daltons |
| 02/02/2006 | US20060024670 Influenza virus vaccine composition and methods of use |
| 02/02/2006 | US20060024669 Using influenza virus peptide as tool in diagnosis and treatment of viral diseases; proteomics; bioinformatics |
| 02/02/2006 | US20060024668 Coronavirus, nucleic acid, protein, and methods for the generation of vaccine, medicaments and diagnostics |
| 02/02/2006 | US20060024666 Humanized antibodies against the venezuelan equine encephalitis virus |
| 02/02/2006 | US20060024665 PRMTs as modifiers of the p53 pathway and methods of use |
| 02/02/2006 | US20060024664 Characterizing purity and activity of polysaccharide preparations including glycosaminoglycans such as heparin |
| 02/02/2006 | US20060024663 Methods for determining the potency, specificity, and toxicity of microsomal prostaglandin E2 synthase |
| 02/02/2006 | US20060024662 Methods for magnetic resonance imaging |
| 02/02/2006 | US20060024661 Modulation of CRF potentiation of NMDA receptor currents via CRF receptor 2 |
| 02/02/2006 | US20060024660 Method for relative quantification of proteins |
| 02/02/2006 | US20060024659 Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same |
| 02/02/2006 | US20060024658 Composition and methods for evaluating an organism's response to alcohol or stimulants |
| 02/02/2006 | US20060024380 Chemical cleaning of biological material |
| 02/02/2006 | US20060024321 chemokines; open reading frames; long terminal repeats; site directed mutagenesis; antibodies |
| 02/02/2006 | US20060024320 Attenuated pestiviruses |
| 02/02/2006 | US20060024312 Methods for enhancing learning and memory |
| 02/02/2006 | US20060024306 Methods of treating and preventing colitis involving il-13 and nk-t cells |
| 02/02/2006 | US20060024305 Camp-regulated phosphoprotein for diagnostic and therapeutic use in neurodegenerative diseases |
| 02/02/2006 | US20060024301 Prostate-specific polypeptides and fusion polypeptides thereof |
| 02/02/2006 | US20060024299 Human osteoclast derived cathepsin |
| 02/02/2006 | US20060024283 Red blood cells loaded with S-nitrosothiol and uses therefor |
| 02/02/2006 | US20060024280 Stem cell-derived endothelial cells modified to disrupt tumor angiogenesis |
| 02/02/2006 | US20060024275 Methods for use of MPL ligands with primitive human stem cells |
| 02/02/2006 | US20060024267 TNFr/OPG-like molecules and uses thereof |
| 02/02/2006 | US20060024234 Protein markers for pharmaceuticals and related toxicity |
| 02/02/2006 | US20060024233 Use of biomolecular targets in the treatment and visualization of brain tumors |
| 02/02/2006 | US20060022113 Imaging methods and apparatus having extended dynamic range |
| 02/02/2006 | US20060021881 For detecting biological and chemical species in liquid and gaseous phase; utilize carbon nanotubes to enhance sensitivity and selectivity towards the reacting species by decreasing interference and detecting a wide range of concentrations; polymer and sensing element immobilized to the carbon nanotube |
| 02/02/2006 | DE19826835B4 Anordnung und Verfahren zur automatischen Bestimmung luftgetragener Mikroorganismen, biotischer und/oder abiotischer Partikel System and method for automatic determination of airborne microorganisms, biotic and / or abiotic particles |
| 02/02/2006 | DE102004034343A1 Amplifying nucleic acid sequences in samples containing other sequences to be suppressed, e.g. in diagnostic tests, with addition of new or known discriminating oligomers of locked nucleic acid type |
| 02/02/2006 | DE10015797B4 Multiplex-Analyse von DNA-Gemischen mittels photolytisch ablesbarer DNA-Chips Multiplex analysis of DNA mixtures by means of photolytically readable DNA chips |
| 02/02/2006 | CA2616277A1 Urine markers for detection of bladder cancer |
| 02/02/2006 | CA2577407A1 Genetic diagnostic method for scd risk stratification |
| 02/02/2006 | CA2575462A1 Mutations in erb2 associated with cancerous phenotypes |
| 02/02/2006 | CA2575422A1 Method of detecting mutations in the gene encoding cytochrome p450-2c19 |
| 02/02/2006 | CA2575217A1 Method for determining the amount of template nucleic acid present in a sample |
| 02/02/2006 | CA2574991A1 Methods for diagnosis of appendicitis |
| 02/02/2006 | CA2574878A1 Methods and compositions involving protein kinase c.delta. |
| 02/02/2006 | CA2574832A1 Method for determining the abundance of sequences in a sample |
| 02/02/2006 | CA2574698A1 Addition of transgenes into adenoviral vectors |
| 02/02/2006 | CA2574654A1 Compositions and methods of use for mgd-csf in disease treatment |
| 02/02/2006 | CA2572384A1 Genetic markers for predicting disease and treatment outcome |
| 02/02/2006 | CA2571445A1 Markers for brain damage |
| 02/02/2006 | CA2566336A1 Dna sequences for the detection of and differentation amongst pathogenic e.coli |
| 02/01/2006 | EP1621890A1 Device and method for separating, mixing and concentrating magnetic particles with a fluid and use thereof in purification methods |
| 02/01/2006 | EP1621889A1 Method for detecting binding of nucleic acid and nucleic acid binding protein by monomolecular fluorescent analysyis |
| 02/01/2006 | EP1621639A2 A novel method of diagnosing, monitoring and staging prostate cancer |
| 02/01/2006 | EP1621638A1 Method of analyzing gene introduction site |
| 02/01/2006 | EP1621637A1 ppGalNac-T6 mRNA or peptide as a new marker for the detection of cancer cells |
| 02/01/2006 | EP1621636A1 Redox polymers for use in electrochemical-based sensors |
| 02/01/2006 | EP1621635A2 Self-assembling recombinant HP16 papillomavirus capsid proteins |
| 02/01/2006 | EP1621634A1 Multiple gene transcription activity determining system |
| 02/01/2006 | EP1621633A2 Glycoproteins produced in plants with suppressed expression of beta 1, 2-xylosyltransferase |
| 02/01/2006 | EP1621627A2 Use of porcine gala (1,3) galactosyl transferase in xenograft therapies |
| 02/01/2006 | EP1621623A2 BASB029 polynucleotide(s) and polypeptides from Neisseria meningitis |
| 02/01/2006 | EP1621620A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/01/2006 | EP1621614A2 Herbicide target genes and methods |
| 02/01/2006 | EP1621545A2 Oligoribonucleotides and ribonucleases for cleaving RNA |
| 02/01/2006 | EP1621530A1 Methods, compositions et enzyme substrates for the detection of Pseudomonas Aeruginosa |
| 02/01/2006 | EP1621204A1 Use of products derived from selenoprotein T in the context of calcium homeostasis |
| 02/01/2006 | EP1621189A2 Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function |
| 02/01/2006 | EP1620823A2 Method for selection of optimal microarray probes |
| 02/01/2006 | EP1620732A2 Claudins' underexpression as markers of tumor metastasis |
| 02/01/2006 | EP1620731A2 Methods of measuring the ability of a test compound to inactivate a biological target in cells of a subject |
| 02/01/2006 | EP1620723A1 Method for identifying modulators of clk-1 and ubif activity |
| 02/01/2006 | EP1620719A2 Biomolecular switching device using a holliday junction dna |
| 02/01/2006 | EP1620575A2 Method of electrochemical detection of somatic cell mutations |
| 02/01/2006 | EP1620574A2 Method for nucleic acid sequencing |
| 02/01/2006 | EP1620573A2 Determining cancer-linked genes and therapeutic targets using molecular cytogenetic methods |
| 02/01/2006 | EP1620571A2 Corn event tc1507 and methods for detection thereof |
| 02/01/2006 | EP1620570A2 Electrochemical method to measure dna attachment to an electrode surface in the presence of molecular oxygen |
| 02/01/2006 | EP1620569A2 A forward mutation assay based on 5-fluorouracil resistance |
| 02/01/2006 | EP1620568A1 Allele-specific mutation detection assay |